Next generation sequencing panel target genes: possible diagnostic tool for ectodermal dysplasia related diseases
Michele Callea1, Emanuele Bellacchio2, Francisco Cammarata Scalisi3
1Unit of Pediatric Dentistry and Special Dental Care, Meyer Children's Hospital IRCCS, Florence, Italy.
Italian Journal of Dermatology and Venereology
|March 20, 2023
Summary
Targeted exome resequencing rapidly diagnoses ectodermal dysplasias (EDs), aiding genetic counseling and treatment. This study identified ED mutations, highlighting the need for genotype-phenotype correlation for personalized care.
Area of Science:
- Genetics
- Molecular Biology
- Dermatology
Background:
- Ectodermal dysplasias (EDs) are a complex group of disorders with significant clinical and genetic heterogeneity.
- Accurate diagnosis of EDs is challenging due to their diverse presentations.
- Recent therapeutic advancements for X-linked hypohidrotic ectodermal dysplasia (XLHED) increase interest in ED genetics.
Purpose of the Study:
- To demonstrate the clinical utility of targeted resequencing for diagnosing EDs.
- To enhance molecular and clinical diagnosis of ectodermal dysplasias.
- To facilitate potential treatments by identifying genetic bases and phenotypic presentations.
Main Methods:
- Assessed seventeen individuals from three unrelated families with phenotypes suggestive of ED.
- Performed multidisciplinary clinical evaluation and targeted exome resequencing panel.
- Utilized MiSeqTM data software, accepting variants with Qscore >30.
Main Results:
- Identified three different previously reported hemizygous EDA mutations in the families.
- A complete genotype-phenotype correlation could not be established in the studied patients or previously reported cases.
Conclusions:
- Targeted exome resequencing offers rapid and accurate diagnosis of EDs, expanding genetic data.
- Identifying disease-causing mutations is crucial for genetic counseling and establishing genotype-phenotype correlations.
- Establishing genotype-phenotype correlations enables more suitable treatment plans for affected individuals.


